1. Home
  2. YORW vs ALT Comparison

YORW vs ALT Comparison

Compare YORW & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo York Water Company (The)

YORW

York Water Company (The)

HOLD

Current Price

$31.26

Market Cap

507.5M

Sector

Utilities

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.81

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YORW
ALT
Founded
1816
1997
Country
United States
United States
Employees
104
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.5M
421.5M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
YORW
ALT
Price
$31.26
$2.81
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$34.00
$17.67
AVG Volume (30 Days)
189.6K
4.6M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
3.13%
N/A
EPS Growth
N/A
25.37
EPS
0.33
N/A
Revenue
$77,488,000.00
$41,000.00
Revenue This Year
$11.78
N/A
Revenue Next Year
$4.95
N/A
P/E Ratio
$95.18
N/A
Revenue Growth
3.37
105.00
52 Week Low
$28.26
$2.56
52 Week High
$34.30
$6.44

Technical Indicators

Market Signals
Indicator
YORW
ALT
Relative Strength Index (RSI) 56.67 43.39
Support Level $30.96 $2.62
Resistance Level $32.83 $3.15
Average True Range (ATR) 0.72 0.17
MACD 0.05 -0.02
Stochastic Oscillator 70.25 7.14

Price Performance

Historical Comparison
YORW
ALT

About YORW York Water Company (The)

The York Water Co is the investor-owned water utility in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. The company also owns and operates three wastewater collection systems and twelve wastewater collection and treatment systems. The company operates within its franchised water and wastewater territory, which covers portions of municipalities within four counties in south-central Pennsylvania. It provides services to diversified, manufacturing such items as fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergent, barbells, and motorcycles.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: